HELP

NASD Helus Pharma Inc.

Oct 8, 2026 · 12:34 AM ET EOD Market Closed

$10.51 ↑ +0.00 (+0.00%) Trading Up from the previous close of $10.51, $0.30 below the day’s high of $10.81

YTD change: +35.96%
vs 20-day SMA: -17.58%
vs 200-day SMA: N/A

Price ranges

Previous day

$10.51 $11.38

open $11.35 close $10.76

-$0.59 (-5.20%)

Today

$10.44 $10.81

open $10.63 now $10.51

-$0.12 (-1.13%)

Past week

$10.51 $12.90

from $12.70 now $10.51

-$2.19 (-17.24%)

Past month

$10.51 $15.15

from $12.39 now $10.51

-$1.88 (-15.17%)

This year

$3.76 $15.15

from $7.73 now $10.51

+$2.78 (+35.96%)

Price & Performance

+5.26 (+100.19%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 30.6% away from all-time highs of $15.15
HELP is up 36% since the beginning of the year
HELP is up 36% over the past 12 months
HELP is down 15% over the past 1 month
4% of all HELP investors are betting against HELP

HELP reads not so good: the 12-month move is +36.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.91

Earnings momentum -28.4% Quarterly EPS growth

Quarterly change -28.4%

Valuation

P/E ratio N/A

Enterprise value $396.3M

Beta 0.32

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$166.4M

DebtN/A

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Mining, Quarrying, and Oil and Gas Extraction

Sub Sector Mining (except Oil and Gas)

Market cap $767.9M

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Competitor comparison

Ticker	Company	Price	Change
CCO.CAT	CAMECO CORP	$126.97	-4.12%
CCJ	Cameco Corporation	$89.07	-4.25%
SOUHY	South32 Ltd. Sponsored ADR	$17.31	-1.68%
OUKPY	Metso Corporation Unsponsored ADR	$9.32	-3.32%
GMINF	G Mining Ventures Corp	$33.91	-2.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.